Research Article
[Retracted] Diagnostic and Staging Value of Serum Angiotensin-Converting Enzyme in Sarcoidosis
Table 3
Comparison between sarcoidosis of different clinical stages.
| | Parameters | Stage I () | Stage II () | Stage III () | value | value |
| | Age (years) | | | | 2.463 | 0.093 | | Gender (male/female) | 1 : 13 | 13 : 37 | 0 : 6 | 4.071 | 0.131 | | sACE (U/L) | | | | 0.262 | 0.771 | | Fever | 2/14 | 14/50 | 2/6 | 1.276 | 0.528 | | Cough | 10/14 | 37/50 | 5/6 | 0.319 | 0.853 | | Shortness of breath | 5/14 | 20/50 | 3/6 | 0.357 | 0.837 | | Weight loss | 0/14 | 12/50 | 2/6 | 4.667 | 0.097 | | FEV1%pred | | | | 8.317 | <0.001 | | FEV1/FVC (%) | | | | 2.913 | 0.061 | | TLC%pred | | | | 2.786 | 0.069 | | DLCO%pred | | | | 5.049 | 0.009 | | WBC (×109/L) | | | | 1.597 | 0.210 | | Lymphocyte (%) | | | | 2.674 | 0.076 | | Hemoglobin (g/L) | | | | 0.918 | 0.404 | | ESR (mm/h) | | | | 0.625 | 0.538 | | CRP (mg/L) | | | | 2.596 | 0.082 | | Serum calcium (mmol/L) | | | | 3.042 | 0.054 | | ADA (U/L) | | | | 3.092 | 0.052 | | PaO2 (mmHg) | | | | 2.182 | 0.121 | | BALF lymphocyte (%) | | | | 0.037 | 0.963 | | BALF neutrophil (%) | | | | 0.477 | 0.623 | | Application of glucocorticoid therapy | 5/14 | 39/50 | 0/6 | 19.483 | <0.001 |
|
|